Congestive Heart Failure Treatment Devices Market Size, Share, and Analysis, By Product Type (Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices), By End User (Hospitals & Clinic, Specialized Cardiovascular Disease Treatment Centres, Ambulatory Surgery Centres) and Regional Forecasts, 2022-2032
Congestive Heart Failure Treatment Devices Market Size, Share, and Analysis, By Product Type (Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices), By End User (Hospitals & Clinic, Specialized Cardiovascular Disease Treatment Centres, Ambulatory Surgery Centres) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW:
The Global Congestive Heart Failure Treatment Devices market size was USD 5.5 billion in 2021 and projected to grow from USD 6.4 billion in 2023 to USD 13 billion by 2032, exhibiting a CAGR of 8% during the forecast period.
Congestive heart failure treatment device is called as mechanical circulatory support system. There are various types of congestive heart failure treatment devices like implantable cardioverter defibrillators, cardiac resynchronization therapy devices, pacemakers, and ventricular assist devices. There are many ventricular assist devices, like left congestive heart failure treatment devices (LVADs), right congestive heart failure treatment devices (RVADs), and others which are utilized as a permanent solution in patients with minor improvement chances of cardiac muscles. The implantable cardiac defibrillator is an electronic device placed inside the body to track rhythm of heart and provide shock to the heart muscle in case of abnormal rhythm.
MARKET HIGHLIGHTS
Global Congestive Heart Failure Treatment Devices Market is expected to project a CAGR of 8% during the forecast period, 2022-2032
Global Congestive Heart Failure Treatment Devices market is expected to reach USD 13 billion at a CAGR of 8% during forecast period owing to the rising prevalence of cardiovascular disorders and increasing risk of organ failure is expected to boost the growth of the market. The increasing investments by the key players in development of congestive heart failure treatment devices is creating an opportunity for the market to grow. The increasing patient count with heart failure has created demand for ventricular assistance devices and is expected to drive the market grow.
GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SEGMENTATION:
Pacemakers segment is expected to grow with high CAGR during forecast period
Global Congestive Heart Failure Treatment Devices Market is classified based on the Product Type into Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices. Pacemakers segment dominated the congestive heart failure treatment devices market in 2021 and is expected to continue during the forecast period due to the rising R&D activities in this industry and increasing demand for congestive heart failure treatment devices for treatment of heart failure using pacemakers. The increasing cardiac surgeries is expected to boost the growth of the market.
Hospitals & Clinic segment is expected to grow with high CAGR during 2022-2032
MARKET DYNAMICS:
Growth Drivers
Global Congestive Heart Failure Treatment Devices Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region dominated the market in 2021 owing to the presence of large patient population affected by cardiovascular disorders along with rising geriatric population. Asia-Pacific region is expected to dominate the market in the forecast period, owing to the high demand for CHF treatment devices. The fast-growing healthcare system in the countries of this region is expected to dominate the growth of the market in this region.
Segmentation
PRODUCT OVERVIEW:
The Global Congestive Heart Failure Treatment Devices market size was USD 5.5 billion in 2021 and projected to grow from USD 6.4 billion in 2023 to USD 13 billion by 2032, exhibiting a CAGR of 8% during the forecast period.
Congestive heart failure treatment device is called as mechanical circulatory support system. There are various types of congestive heart failure treatment devices like implantable cardioverter defibrillators, cardiac resynchronization therapy devices, pacemakers, and ventricular assist devices. There are many ventricular assist devices, like left congestive heart failure treatment devices (LVADs), right congestive heart failure treatment devices (RVADs), and others which are utilized as a permanent solution in patients with minor improvement chances of cardiac muscles. The implantable cardiac defibrillator is an electronic device placed inside the body to track rhythm of heart and provide shock to the heart muscle in case of abnormal rhythm.
MARKET HIGHLIGHTS
Global Congestive Heart Failure Treatment Devices Market is expected to project a CAGR of 8% during the forecast period, 2022-2032
Global Congestive Heart Failure Treatment Devices market is expected to reach USD 13 billion at a CAGR of 8% during forecast period owing to the rising prevalence of cardiovascular disorders and increasing risk of organ failure is expected to boost the growth of the market. The increasing investments by the key players in development of congestive heart failure treatment devices is creating an opportunity for the market to grow. The increasing patient count with heart failure has created demand for ventricular assistance devices and is expected to drive the market grow.
GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SEGMENTATION:
Pacemakers segment is expected to grow with high CAGR during forecast period
Global Congestive Heart Failure Treatment Devices Market is classified based on the Product Type into Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices. Pacemakers segment dominated the congestive heart failure treatment devices market in 2021 and is expected to continue during the forecast period due to the rising R&D activities in this industry and increasing demand for congestive heart failure treatment devices for treatment of heart failure using pacemakers. The increasing cardiac surgeries is expected to boost the growth of the market.
Hospitals & Clinic segment is expected to grow with high CAGR during 2022-2032
MARKET DYNAMICS:
Growth Drivers
- Rising Technological Advancements is Expected to Boost the Growth of the Market
- Increasing Prevalence of Cardiac Disorders will Drive the Market Growth
- High Cost of the Treatment Devices May Restrain the Market Growth
- Boston Scientific Corporation
- Abbott
- Johnson & Johnson Services, Inc
- Mayo Foundation
- Medtronic PLC
- Biotronik SE & Co., KG
- LivaNova PLC
- Berlin Heart GmbH
- Abiomed, Inc.
- ReliantHeart Inc.
- St. Jude Medical
- Teleflex, Inc.
- Edwards Lifesciences Corporation
- Jarvik Heart, Inc.
- MicroPort Scientific Corporation
- Other Prominent Players
Global Congestive Heart Failure Treatment Devices Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region dominated the market in 2021 owing to the presence of large patient population affected by cardiovascular disorders along with rising geriatric population. Asia-Pacific region is expected to dominate the market in the forecast period, owing to the high demand for CHF treatment devices. The fast-growing healthcare system in the countries of this region is expected to dominate the growth of the market in this region.
Segmentation
- Product Type
- Pacemakers
- Cardiac Resynchronization Therapy
- Implantable Cardioverter Defibrillators
- Ventricular Assist Devices
- By End User
- Hospitals & Clinic
- Specialized Cardiovascular Disease Treatment Centres
- Ambulatory Surgery Centres
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
1 EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2. Business Trends
1.3. Congestive Heart Failure Treatment Devices Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Congestive Heart Failure Treatment Devices Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Pacemakers
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Cardiac Resynchronization Therapy
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Implantable Cardioverter Defibrillators
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Ventricular Assist Devices
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By End User
11.3.2.1. Hospitals & Clinic
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Specialized Cardiovascular Disease Treatment Centers
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Ambulatory Surgery Centers
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Boston Scientific Corporation
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Abbott
18.3. Johnson & Johnson Services, Inc
18.4. Mayo Foundation
18.5. Medtronic PLC
18.6. Biotronik SE & Co., KG
18.7. LivaNova PLC
18.8. Berlin Heart GmbH
18.9. Abiomed, Inc.
18.10. ReliantHeart Inc.
18.11. St. Jude Medical
18.12. Teleflex, Inc.
18.13. Edwards Lifesciences Corporation
18.14. Jarvik Heart, Inc.
18.15. MicroPort Scientific Corporation
18.16. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Congestive Heart Failure Treatment Devices Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Congestive Heart Failure Treatment Devices Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Pacemakers
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Cardiac Resynchronization Therapy
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Implantable Cardioverter Defibrillators
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Ventricular Assist Devices
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By End User
11.3.2.1. Hospitals & Clinic
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Specialized Cardiovascular Disease Treatment Centers
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Ambulatory Surgery Centers
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Boston Scientific Corporation
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Abbott
18.3. Johnson & Johnson Services, Inc
18.4. Mayo Foundation
18.5. Medtronic PLC
18.6. Biotronik SE & Co., KG
18.7. LivaNova PLC
18.8. Berlin Heart GmbH
18.9. Abiomed, Inc.
18.10. ReliantHeart Inc.
18.11. St. Jude Medical
18.12. Teleflex, Inc.
18.13. Edwards Lifesciences Corporation
18.14. Jarvik Heart, Inc.
18.15. MicroPort Scientific Corporation
18.16. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
